Navigation Links
New Research Results Show That Investigational Drug Phenoxodiol,Targets Cancer Protein, Causing Cancer Cell Death

rug sensitivity to resistant cancer cells.

"Phenoxodiol has a unique mechanism of action not exhibited by other anticancer drugs in current use.," said Dr. Berridge. "By inhibiting plasma membrane electron transport selectively in cancer cells, phenoxodiol subjects these cells to stress that leads to cell death. This novel drug and its related analogues have the potential to enhance anticancer efficacy by a different mechanism, promising a new approach to management of solid tumors in a range of clinical settings. As the first compound to operate via this pathway, confirmatory evidence to validate the mechanism of action is very desirable."

Specific Findings Identify Specific Proteins Associated with Unlocking the Mystery for Why Cancer Cells don't Die the Way Healthy Cells Do

Evidence from this new study indicates that phenoxodiol inhibits proliferation of many cancer cell lines and some primary immune cells. Phenoxodiol induces the destruction of cancer cells by disrupting a stress pathway in the outer cell membrane, causing down regulation of the FLICE-inhibitory protein, FLIP, and resulting in caspase-dependent and independent degradation of the X-linked inhibitor of cell death, XIAP.

Phenoxodiol selectively limits plasma membrane electron transport in cancer cells, by binding to a cancer specific surface plasma membrane electron transport element on cancer cells thereby inhibiting their proliferation, whereas the compound has no such effect on normal healthy cells.

Multinational trial underway

Phenoxodiol in combination with carboplatin is currently being studied in a multi-national Phase III clinical trial called OVATURE, following positive findings of previous trials conducted at Yale-New Haven Hospital. The OVATURE trial will take place in 60 sites in the United States, Europe, and Australia. Preliminary results from the trial are expected within 18 months.

About phenoxodiol:

Phenoxodiol is being develo
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. NIEHS Researchers Identify Enzyme Critical in DNA Replication
2. Stanford Researchers Find Brain Pathway of Depression in Rats
3. Suven Life Sciences Presenting Pre-clinical data of their NCE’s SUVN-502 and SUVN-507at International Brain Research Organization (IBRO) 2007 World Congress of Neuroscience
4. From Clinical Cancer Research: Rethinking Therapeutic Cancer Vaccine Trials
5. Researchers Discover Method for Identifying How Cancer Evades the Immune System
6. Infertile Voice Supports Stem Cell Research: RESOLVE Calls for Patient Options in Using Frozen Embryos
7. Fact Sheet: Advancing Stem Cell Research While Respecting Moral Boundaries
8. President Bush Ignores Americas Plea for Support of Stem Cell Research
9. Researchers Discover Gene For Rare Skin Disorder
10. The Christopher and Dana Reeve Foundation Expresses Disappointment Over President Bushs Veto of the Stem Cell Research Enhancement Act
11. Research on New Treatment for Neglected Disease Published in The New England Journal of Medicine

Post Your Comments:
(Date:11/9/2009)...ON, Calif., Nov. 9 Thora...n device-based mechanical circulatory support ther... said today that it will be participating in the T... Tuesday, November 10. ,, The presentation by G...cer, will begin at 8 a.m., Pacific Standard Time (...
(Date:11/9/2009)... Mass., Nov. 9 Hologic, ...leading developer, manufacturer and supplier of pr...gical products dedicated to serving the healthcare...he fourth quarter and fiscal year ended September ... Board of Directors has promoted Robert Cascella t...
(Date:11/9/2009)..., PRINCETON, N.J., Nov. 9 /PRNewswire-FirstCall/...nagement will present at the Sixth Annual Lazard C...ce will be held at the St Regis Hotel in New York ... Pharmasset,s President and Chief Executive Office...esday, November 18, 2009 at 3:45 PM (ET). ,, To...
Breaking Medicine Technology:Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 2Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 3Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 4Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 5Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 7Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 8Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 9Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 10Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 11Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 12Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 13Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 14Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 15Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 16Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 17Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 18Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 19Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 20Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 21Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 22Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 23Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 24Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 25Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 26Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 27Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 28Pharmasset to Present at Lazard Capital Markets Healthcare Conference 2Pharmasset to Present at Lazard Capital Markets Healthcare Conference 3FDA Clears a Test for Ovarian Cancer 4972 1FDA Clears a Test for Ovarian Cancer 4972 2Professor Uses H1N1 as a Teaching Tool 56956 1Professor Uses H1N1 as a Teaching Tool 56956 2Professor Uses H1N1 as a Teaching Tool 56956 3Muslim Coalition to Host D C Hearing on Health Care Reform 56951 1Muslim Coalition to Host D C Hearing on Health Care Reform 56951 2
...eleased,results from two previously published stud...e combination asthma therapy SYMBICORT(R),(budeson...sol achieved,bronchodilation, or opening of the ai...heir medication begin to work right away.(1) The s...ent perception of onset of,effect(1) of SYMBICORT ...
...e Target Discredited; Lower Dose, Array of ...ct, SAN DIMAS, Calif., Sept. 10 While the red wi...cently attracted scientific and,public attention a...ffects,of a calorie-restricted diet, the science s... in recent months, according to Bill Sardi,spokesp...
Other Medicine Technology:Newly Released Data on Onset of Effect and Patient Perception With SYMBICORT in Adults With Asthma 2Newly Released Data on Onset of Effect and Patient Perception With SYMBICORT in Adults With Asthma 3Newly Released Data on Onset of Effect and Patient Perception With SYMBICORT in Adults With Asthma 4Newly Released Data on Onset of Effect and Patient Perception With SYMBICORT in Adults With Asthma 5Newly Released Data on Onset of Effect and Patient Perception With SYMBICORT in Adults With Asthma 6Resveratrol Longevity Science Makes Dramatic U-Turn, But Resveratrol Supplements Remain Unchanged 2Resveratrol Longevity Science Makes Dramatic U-Turn, But Resveratrol Supplements Remain Unchanged 3Resveratrol Longevity Science Makes Dramatic U-Turn, But Resveratrol Supplements Remain Unchanged 4
(Date:11/9/2009)...y finds , , MONDAY, Nov. 9 (HealthDay Ne...ial enlargement, which increases the risk of atria...s. , Atrial fibrillation is the most common typ...tbeat). , Researchers analyzed data on 1,212 m...ollowed for 10 years. The study authors concluded ...
(Date:11/9/2009)...rybody,s buzz word today and for Recruiters and St...cruiters and Staffers create their own private net...d close positions. The site also enables individua...ith recruiters. , (PRWEB)...ryone to network more than ever and by the launch ...
(Date:11/9/2009)...od despite similar weight loss , , MONDA...-carbohydrate diet such as the popular Atkins prog...eople lose pounds over the course of a year. ,...lt in long-term improvement in mood, according to ...al Medicine . , People on both diets consumed r...
(Date:11/9/2009)...irstCall/ - Hard To Treat Diseases (HTDS.PK) www.... US$41 billion international healthcare company, i...tner, Zhejiang Tianyuan Bio-Pharmaceutical Co., Lt...ll begin a five-year, $1 billion China initiative ...ase its investment in its China R&D facility, ...
(Date:11/9/2009)...ered in April 2010, Provides First Responders with...bridge, MA (Vocus) November 9, 2009 -- When Stefan...t inspected a suspected mass grave at Dasht-e-Lei...am of experts to help interpret the scene. He knew...t step in securing evidence of a human rights viol...
Breaking Medicine News(10 mins):Health News:Launching StaffingClub.com, a New Online Networking Platform for Recruiting and Staffing Professionals 2Health News:To Feel Better, Low-Fat Diet May Be Best 2Health News:To Feel Better, Low-Fat Diet May Be Best 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 2Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 4Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 2Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 3Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 4
... & Health Insurance Company (ELH), a subsidiar...IHI ), announced today that it will add vision to ...vision products include a vision insurance plan an...of the most requested employee benefits from a car...
...Relief and Development (LIFE), a U.S.-based charit...ef to the civilian victims of the recent conflict ...ational non-governmental organizations operating i...itarian corridor. , , LIFE has distributed food...
...nsider strategic alternatives , , MADISON, Wis., ... of Avalon Capital Group, announced that on Decemb...ve on the board of TomoTherapy Inc. (Nasdaq: TOM...in TomoTherapy,s stock price since 2007. The compa...
...rom itraconazole, study finds , , MONDAY,...y offer hope for severe asthma patients who also s...ritish study says. , A twice-daily dose of itracon...st one of seven different common fungi in the doub...
...ra, Inc.,(NYSE: HSP ), a global specialty pharma...nounced that Christopher B. Begley, chairman and c...or vice president, Finance, and,chief financial of... in San Francisco. , The presentation is ...
...ence in a high-fat diet can not only lead to overw...o can affect the balance of circadian rhythms eve...y of Jerusalem researchers have shown. , The bio...henomena as hormone imbalance, obesity, psychologi...
Other Medicine News:Health News:Eastern Life & Health Introduces New Vision Product 2Health News:Eastern Life & Health Introduces New Vision Product 3Health News:Avalon Portfolio Nominates Slate of Directors for TomoTherapy Board 2Health News:Avalon Portfolio Nominates Slate of Directors for TomoTherapy Board 3Health News:Another reason to avoid high-fat diet -- it can disrupt our biological clock 2
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
Medicine Products: